Bayer AG v O'Hagan Medical Pty Ltd

Bayer AG (Bayer) brought proceedings against O'Hagan Medical Pty Ltd (O'Hagan Medical) in the Federal Court of Australia. The dispute concerned O'Hagan Medical's use of the trade mark "BAYER" in relation to its medical devices and services, which Bayer alleged constituted trade mark infringement and misleading or deceptive conduct. Bayer, a global pharmaceutical and life sciences company, argued that O'Hagan Medical's use of the "BAYER" mark was likely to cause confusion among consumers and damage its reputation.

The primary legal issues before the Court were whether O'Hagan Medical's use of the "BAYER" mark infringed Bayer's registered trade marks, and whether such use constituted misleading or deceptive conduct in contravention of the Australian Consumer Law. Specifically, the Court had to determine if there was a likelihood of deception or confusion in the marketplace given the similarity of the marks and the nature of the goods and services offered by both parties.

Justice Wilson found that O'Hagan Medical's use of the "BAYER" mark was indeed likely to cause confusion and therefore infringed Bayer's registered trade marks. The Court applied the principles of trade mark law, focusing on the likelihood of deception or confusion as the key test for infringement. It considered the distinctiveness of Bayer's mark, the similarity between the marks, and the nature of the goods and services. Furthermore, the Court held that O'Hagan Medical's conduct was misleading or deceptive under the Australian Consumer Law, as consumers would likely be led to believe there was an association between O'Hagan Medical and Bayer.

The Court ordered that O'Hagan Medical be restrained from using the "BAYER" mark in relation to its medical devices and services, and that it pay Bayer's costs.